Immunic, Inc. (IMUX)
Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies for the treatment of chronic inflammatory and autoimmune diseases. Its lead development program is IMU-838, which is in Phase 2 clinical for treatment of relapsing-remitting multiple sclerosis, inflammatory bowel disease, and other chronic inflammatory and autoimmune diseases, as well as to treat coronavirus disease. The company is also developing IMU-935, an inverse agonist of ROR?t; and IMU-856 for the restoration of the intestinal barrier function in patients suffering from diseases, such as inflammatory bowel disease, irritable bowel syndrome with diarrhea, immune checkpoint inhibitor induced colitis, and other intestinal barrier function diseases. Immunic, Inc. is headquartered in New York, New York.
$175.65M
Dr. Daniel Vitt
65.00
New York, NY
Apr 17, 2014
-1.30
$-1.50
3.51
3.75
0.00%
-1.71
0.00
2.56
0.00
3.75
-110.19%
-169.82%
Similar stocks (13)
Kymera Therapeutics, Inc.
KYMR
Edgewise Therapeutics, Inc.
EWTX
Nurix Therapeutics, Inc.
NRIX
Erasca, Inc.
ERAS
Foghorn Therapeutics Inc.
FHTX
C4 Therapeutics, Inc.
CCCC
Monte Rosa Therapeutics, Inc.
GLUE
Generation Bio Co.
GBIO
Shattuck Labs, Inc.
STTK
Kronos Bio, Inc.
KRON
Kezar Life Sciences, Inc.
KZR
Eyenovia, Inc.
EYEN
Spruce Biosciences, Inc.
SPRB
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.03291%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%
Similar stocks (13)
Kymera Therapeutics, Inc.
KYMR
Edgewise Therapeutics, Inc.
EWTX
Nurix Therapeutics, Inc.
NRIX
Erasca, Inc.
ERAS
Foghorn Therapeutics Inc.
FHTX
C4 Therapeutics, Inc.
CCCC
Monte Rosa Therapeutics, Inc.
GLUE
Generation Bio Co.
GBIO
Shattuck Labs, Inc.
STTK
Kronos Bio, Inc.
KRON
Kezar Life Sciences, Inc.
KZR
Eyenovia, Inc.
EYEN
Spruce Biosciences, Inc.
SPRB
ETF Exposure (11)
iShares Micro-Cap ETF
IWC
0.03291%
Vanguard Balanced Index Fund Institutional Shares
VBAIX
0%
Vanguard Balanced Index Fund Admiral Shares
VBIAX
0%
Vanguard Balanced Index Fund
VBINX
0%
Vanguard Extended Market Index Fund Institutional Shares
VIEIX
0%
Vanguard Institutional Total Stock Market Index Fund Institutional Shares
VITNX
0%
Vanguard Institutional Total Stock Market Index Fund
VITPX
0%
Vanguard Total Stock Market Index Fund
VITSX
0%
Vanguard Total Stock Market Index Fund
VTI
0%
Vanguard Total Stock Market Index Fund
VTSAX
0%
Vanguard Extended Market Index Fund
VXF
0%